Strategy to small intestine obstruction caused by Crohn’s disease on the basis of transnasal ileus tube insertion

BMC Surgery

Table 6 Nutrition time, operative methods, postoperative pathology and postoperative treatment of 6 patients

Characteristics	Patient1	Patient 2	Patient 3	Patient 4	Patient 5	Patient 6
Retention time of intestinal obstruction catheter (week)	4	7	4	6	3	6
Reasons for pulling out of intestinal obstruction catheter	Throat pain	Surgery	Throat pain	Throat pain	Throat pain	Surgery
Nutrition period after tube insertion(week)	8	7	6	7	4	6
Operative methods
Small intestine resection	Yes	Yes	Yes	Yes	Yes	Yes
Colectomy	No	No	Yes	No	Yes	Yes
Residual small intestine length	300 cm	400 cm	300 cm	250 cm	290 cm	300 cm
Intestinal lysis	Yes	No	Yes	Yes	Yes	No
Fistula repair	Yes	No	No	Yes	Yes	No
Ileostomy
Stoma number	2	1	1	2	1	1
Permanent	No	No	Yes	No	No	No
Closure enterostomy	Yes	No	No	Yes	No	No
Postoperative fistula	No	No	No	No	No	No
Incision infection/abdominal infection	No	Yes	No	No	No	No
Postoperative pathology
Acute an chronic inflammation	Moderate-severe	Moderate-severe	Moderate	Moderate	Moderate	Moderate
Transmural inflammation	Yes	Yes	Yes	No	Yes	No
Pseudopolyp	Yes	Yes	No	Yes	Yes	Yes
Ulcer	Superficial	Transmural	Superficial	No	Transmural	No
Serous fibrous hyperplasia	No	Yes	Yes	Yes	Yes	No
Postoperative treatment
Immunosuppressant	No	No	AZA for 0.5y Thalidomide for 1y	No	No	No
EN	Yes	Yes	Yes	Yes	Yes	Yes
Biological agents	Infliximab (start form 1 mon after surgery)	No	Vedolizumab (start form 1 year after surgery)	Vedolizumab (start form 4 mon after surgery)	NO YET	Vedolizumab (start form 1 mon after surgery)
Follow-up postoperation	13M	Lost	3M	7M	2W	2M

ISSN: 1471-2482